Please complete the CAPTCHA to continue
@fmc.com
✓
15 phones found area 215, 860, 610, 480, 474, and 609
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Daniel Rosenbaum is listed as CEO | CFO | Strategic Advisor | Early Stage Ventures at Burkland, based in New York City Metropolitan Area, United States, United States. AeroLeads shows a work email signal at fmc.com, phone signal with area code 215, 860, 610, 480, 474, 609, and a matched LinkedIn profile for Daniel Rosenbaum.
Daniel Rosenbaum previously worked as Consulting CFO at Burkland and CEO at Kaydence Pharma. Daniel Rosenbaum holds Mba, Strategy, Finance, Operations from The Tuck School Of Business At Dartmouth.
This section adds company-level context without repeating Daniel Rosenbaum's masked contact details.
AeroLeads found 1 current-domain work email signal for Daniel Rosenbaum. Compare company email patterns before reaching out.
Innovative, high energy senior leader with global, multi-cultural background and experience. Functional strengths include: Finance, strategy, general management and business development. Proven successes in: business turnarounds, international assignments, strategic planning, financial management, acquisitions and startups. Known as creative and analytical synthesizer who builds motivated, high performance organizations. Strong customer focus, passion for learning, excellent interpersonal skills and drive for measurable results.
Listed skills include Mergers And Acquisitions, Strategy, Strategic Planning, Management, and 19 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
San Francisco, California, US
Burkland Associates helps young companies grow with confidence by providing expert on-demand CFO cover and guidance on strategic planning, financial modeling, operations development, bookkeeping, fundraising, and growth management. We provide financial expertise that makes economic sense for all growth stages - ranging from Pre-Seed to Series C. Our.
New Brunswick, New Jersey, US
Kaydence Pharma is an early stage pharmaceutical company focused on the regulatory and clinical development of menaquinone-7 (vitamin K2-MK7) and addressing a broad range of cardio-vascular and calcification-related diseases. In December, 2017, KP was spun-off from NattoPharma ASA, a company that has led in the clinical validation and commercialization of.
Marcq En Baroeul, FR
Chief Executive Officer of NattoPharma, worldwide innovator and leader of Vitamin K2 menaquinone-7
Marcq En Baroeul, FR
Chief Operating Officer of NattoPharma, worldwide innovator and leader of Vitamin K2 menaquinone-7
Philadelphia, Pennsylvania, US
Full P&L responsibility for leading, integrating and managing $345 million acquisition of premium Omega-3 producer, with operations in Norway and UK.
Philadelphia, Pennsylvania, US
Full P&L responsibility for $300+ million division serving the pharmaceutical industry with functional ingredients
Philadelphia, Pennsylvania, US
Full P&L responsibility for specialty ag division within Ag Products Group, serving wide range of end-user markets, including public health, lawn care, golf and consumer segments.Head of Ag Global Mergers and Acquisitions, responsible for acquisitions and in-licensing, for global Ag Products Group ($2+ billion revenue);Resposible for group strategy.
Philadelphia, Pennsylvania, US
Managed all finance, treasury, credit and collection operations covering all FMC Ag South American operations;Led all marketing activities and strategic planning which resulted in full business restructuring and segment prioritization;
Philadelphia, Pennsylvania, US
General manager of 15 person AZ-based software startup business unit which functioned as part of specialty ag division;Planning and control manager: led finance/planning department charged with financial management, strategic planning and customer operations.
Quick answers generated from the profile data available on this page.
Daniel Rosenbaum works for Burkland.
Daniel Rosenbaum is listed as CEO | CFO | Strategic Advisor | Early Stage Ventures at Burkland.
AeroLeads has found 1 work email signal at @fmc.com for Daniel Rosenbaum at Burkland.
AeroLeads has found 15 phone signal(s) with area code 215, 860, 610, 480, 474, 609 for Daniel Rosenbaum at Burkland.
Daniel Rosenbaum is based in New York City Metropolitan Area, United States, United States while working with Burkland.
Daniel Rosenbaum has worked for Burkland, Kaydence Pharma, Nattopharma Asa, and Fmc Corporation.
You can use AeroLeads to view verified contact signals for Daniel Rosenbaum at Burkland, including work email, phone, and LinkedIn data when available.
Daniel Rosenbaum holds Mba, Strategy, Finance, Operations from The Tuck School Of Business At Dartmouth.
Daniel Rosenbaum is listed with skills including Mergers And Acquisitions, Strategy, Strategic Planning, Management, Cross Functional Team Leadership, Business Planning, Leadership, and Product Development.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts